FBLN7
Fibulin-7
Also known as: FBLN7_HUMAN, FLJ37440, TM14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53RD9
- Gene
- FBLN7
- Ensembl
- ENSG00000144152
- Chromosome
- 2
- Canonical length
- 439 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Cell Junctions
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
Predicted to enable calcium ion binding activity; heparan sulfate proteoglycan binding activity; and heparin binding activity. Predicted to be involved in cell adhesion. Located in focal adhesion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
439 residues, UniProt reviewed canonical sequence.
>Q53RD9|FBLN7
1 MVPSSPRALF LLLLILACPE PRASQNCLSK QQLLSAIRQL QQLLKGQETR FAEGIRHMKS
61 RLAALQNSVG RVGPDALPVS CPALNTPADG RKFGSKYLVD HEVHFTCNPG FRLVGPSSVV
121 CLPNGTWTGE QPHCRGISEC SSQPCQNGGT CVEGVNQYRC ICPPGRTGNR CQHQAQTAAP
181 EGSVAGDSAF SRAPRCAQVE RAQHCSCEAG FHLSGAAGDS VCQDVNECEL YGQEGRPRLC
241 MHACVNTPGS YRCTCPGGYR TLADGKSCED VDECVGLQPV CPQGTTCINT GGSFQCVSPE
301 CPEGSGNVSY VKTSPFQCER NPCPMDSRPC RHLPKTISFH YLSLPSNLKT PITLFRMATA
361 SAPGRAGPNS LRFGIVGGNS RGHFVMQRSD RQTGDLILVQ NLEGPQTLEV DVDMSEYLDR
421 SFQANHVSKV TIFVSPYDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FBLN7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 12 nTPM
- blood vessel: 12 nTPM
- cerebral cortex: 10 nTPM
- thyroid gland: 10 nTPM
- cervix: 9.7 nTPM
- lymph node: 9.2 nTPM
Single-cell type
- oocytes: 166 nCPM
- thyrotrophs: 81 nCPM
- somatotrophs: 66 nCPM
- myosatellite cells: 61 nCPM
- ependymal cells: 55 nCPM
- lactotrophs: 39 nCPM
Immune cell
- T-reg: 37 nTPM
- memory CD4 T-cell: 35 nTPM
- naive CD4 T-cell: 30 nTPM
- total PBMC: 6.2 nTPM
- MAIT T-cell: 1.3 nTPM
- naive CD8 T-cell: 1 nTPM
Brain region
- pons: 24 nTPM
- cerebral cortex: 18 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 13 nTPM
- thalamus: 13 nTPM
- cerebellum: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- Sushi/SCR/CCP domain
- EGF-like domain
- EGF-like calcium-binding domain
- EGF-like calcium-binding, conserved site
- Sushi/SCR/CCP superfamily
- NOTCH1, EGF-like calcium-binding domain
- Extracellular matrix structural protein
- Fibulin, C-terminal Ig-like domain
- EGF-like domain
- Sushi repeat (SCR repeat)
- Calcium-binding EGF domain
- Coagulation Factor Xa inhibitory site
- Fibulin C-terminal Ig-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FBLN7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FBLN7 as an antibody target. Whether an autoantibody or antibody against FBLN7 could matter depends on whether native FBLN7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FBLN7 is annotated as secreted, so native FBLN7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FBLN7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...